King Names COO Markison Acting CEO; President Macione Steps Down
Executive Summary
King Pharmaceuticals Chief Operating Officer Brian Markison has been named acting president and CEO
You may also be interested in...
Mylan Places Big Bet On Antihypertensives: $4 Bil. Deal For King
Mylan's proposed acquisition of King is a big move by the generic company to carve out a leading position in the branded antihypertensive market
King Altace Inventory Levels To Be Stabilized Through Wholesaler Agreements
King Pharmaceuticals is working with wholesalers to implement an inventory reduction program to help stabilize Altace stocking levels, CFO Jim Lattanzi said during a Feb. 19 conference call
King Ups Medicaid Rebate Underpayment Estimate To $65 Mil.; CEO To Depart
King Pharmaceuticals is raising its estimated Medicaid rebate underpayments by $18.9 mil. to $65.4 mil. following the completion of an internal audit, CFO Jim Lattanzi said during a Feb. 19 conference call